SERM
SERM stands for Selective Estrogen Receptor Modulator. It refers to a class of drugs that act on estrogen receptors in the body. SERM is not a laboratory test or an analytical method.
Also called: Selective Estrogen Receptor Modulator, SERMs
A Selective Estrogen Receptor Modulator (SERM) is a synthetic drug class that binds to estrogen receptors in the body. It is important to clarify that a SERM is not a laboratory test, an analytical method, or a measuring instrument, as it does not quantify or measure substances in a laboratory setting.
SERMs produce tissue-specific agonist and antagonist effects
SERMs act differently depending on the tissue type, producing opposite effects in various parts of the body. They can stimulate estrogen-like activity (agonist action) in tissues like bone or liver while blocking it (antagonist action) in breast tissue. This occurs because the SERM changes the shape of the estrogen receptor after binding, which triggers different responses based on the tissue. This specific behavior allows SERMs to be used for conditions like ER+ breast cancer, where blocking estrogen is necessary, and osteoporosis, where bone-preserving activity is required.
- tamoxifen
- raloxifene
- toremifene
Listing SERM as a testing parameter on a COA is a red flag
If a Certificate of Analysis (COA) for a peptide or research chemical lists "SERM" as a testing parameter, it should be treated as a red flag. No authoritative source defines SERM as a laboratory test or analytical method. A valid lab report must instead list recognized methods such as High-Performance Liquid Chromatography (HPLC) for purity testing and Mass Spectrometry (MS) for identity confirmation.
SERM is also frequently confused with SARM (Selective Androgen Receptor Modulator). While both are drug classes targeting different receptors, neither term refers to a valid laboratory test.
Sources
- Selective estrogen receptor modulators: tissue specificity and clinical utility
- Selective Estrogen Receptor Modulators - PMC - NIH
- The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options
- Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention
- New Selective Estrogen and Androgen Receptor Modulators - PMC
- Selective Androgen Receptor Modulators - LiverTox - NCBI Bookshelf
- Selective Estrogen Receptor Modulators - LiverTox - NCBI Bookshelf
- Selective Estrogen Receptor Modulators
- Selective estrogen receptor modulator - Wikipedia
- HPLC vs Mass Spectrometry for Peptide Purity Testing - CertaPeptides
- Peptide Testing: HPLC & Mass Spec Purity Guide | Apex
- Selective Estrogen Receptor Modulators (SERMs)
- Frontiers | Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action
- Frontiers | Pharmacotherapeutic considerations of selective estrogen receptor modulators for vascular protection
- Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice | New England Journal of Medicine
- Definition of the Molecular and Cellular Mechanisms Underlying the Tissue-selective Agonist/Antagonist Activities of Selective Estrogen Receptor Modulators
- Definition of selective estrogen receptor modulator - NCI Dictionary of Cancer Terms - NCI
- SERMs What They Are, How They Work & Their Side Effects